1Gough SC. The genetics of Graves disease. Endocrinol Metab Clin North Am,2000,29(2):255-266.
2Polymeropoulos MH, Xiao H, Rath DS, et al. Dinucleotide repeat polymorphism at the human CTLA-4 gene. Nucleic Acids Res, 1991,19(14):4018.
3Kouki T, Gardine CA, Yanagawa T, et al. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves disease. J Endocrinol Invest, 2002,25(3): 208-213.
4Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, et al. CTLA-4 gene polymorphisms in Tunisian patients with Graves' disease. J Clin Immunol, 2001, 101(3):361-365.
5Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphisms is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol, 1997,46(5):551-554.
6Dariavach P, Mattei MG, Golstein P, et al. Human Ig superfamily CTLA-4 gene: chromosomal localization and identity of protein sequence between murine and human CTLA-4 cytoplasmic domains. Eur J Immunol, 1998,18(12):1901.
7Heward JM, Allahabadia A, Armitage M, et al. The development of Graves' disease and the CTLA4 gene on chromosome 2q^33. J Clin Endocrinol Metab,1999, 84(7):2398-2401.
8Tomer Y, Greenberg DA, Barbesino G, et al. CTLA4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab,2001,86(4): 1687-1693.
9Kinjo Y,Takasu N, Komiya I, et al. Remision of Graves' hyperthyroidism and A/G polymorphism at position 49 in exon 1 of cytotoxic T lymphocyte-associated molecule-4 gene. Clin Endocrinol Metab,2002,87(6):2593-2596.
10Bartalena, L,Marcocci, C.,Tanda, M.L.,Manetti, L.,Dell‘Unto, E.,Bartolomei, M.P.,Nardi, M.,Martino, E.,Pinchera, A.Cigarette smoking and treatmentoutcomes in Graves’ ophthalmopathy[].Ann Intern Med.1998
4Varpula M, Pulkki K, Karlsson S, et al. Predictive value of N-ter- minal pro-brain natriuretic peptide in severe sepsis and septic shock [J]. Crit Care Med, 2007,35(5):1277-1283.
5Waterhoues P, Penninger JM, Timms E, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-d [ J ]. Sci- ence, 1995,270 (5238) :985-988.
6Li HS, Ligons DL, Rose NR. Genetic complexity of autoimmune myocarditis [ J ]. Autoimmunity Rev, 2008,7 ( 3 ) : 168-173.
7Hagiya M, Francarilla A, Polimeno L, et al. Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: ex- pression of biologically active reeomblnation ALR and demonstration of tissue distribution[J]. Proc Natl Aead Sci USA, 1994,91 (17) : 8142-8146.
8Firestein GS. Evolving concepts of rheumatoid arthritis[ J ]. Nature, 2003,423 (6937) : 356-361.
9Kristiansen OP, Larsen ZM, Pociot F. CTLA4 in autoimmune dis- ease-a general susceptibility gene to autoimmunity [ J ]. Genes im- mun, 2000,1(3) :170-184.
10Varpula M,Pulkki K,Karlsson S,et al. Predictive value of N-terminal pro brain natriuretic peptide in severe sepsis and septic shock[J]. Crit Care Meal,2007,35(5) : 1 277-1 283.
